NASDAQ
Damora Therapeutics, Inc. (GLTO) has a fcf yield of -21.31% as of Monday, August 3, 2026. This represents a 88.71% increase compared to its 12-month average of -188.82%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.